Overall, these preclinical and clinical findings demonstrate the pathological roles of NOX4 in various heart diseases, where its increased activity contribute to disease progression, thereby supporting NOX4 as a promising therapeutic target. The gene discussed is NOX4; the disease is heart disorder.